Search results
Julie Louise Gerberding (born August 22, 1955) is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH).
Mar 1, 2022 · North Bethesda, MD, March 1, 2022 – The Foundation for the National Institutes of Health (FNIH) today announced the appointment of Dr. Julie Louise Gerberding, the 15th Director of the Centers for Disease Control and Prevention (CDC) and an executive at Merck & Co., Inc., as its next Chief Executive Officer. Dr.
Year: 2002. Achievement: Dr. Julia Louise Gerberding is the first woman to be appointed director of the Centers for Disease Control (CDC) in Atlanta, Georgia.
Mar 18, 2022 · The Foundation for the National Institutes of Health appointed Dr. Julie Louise Gerberding as its next chief executive officer. She will assume her role on May 16.
Jan 28, 2020 · As director of the Centers for Disease Control and Prevention during that time, Dr. Julie Gerberding led the U.S. public health response to SARS. She is now chief patient officer for Merck & Co....
Experience. Foundation for the National Institutes of Health. Bethesda, Maryland, United States. - Washington, DC. - Education. University of California, San Francisco - School of Medicine. 1981 -...
- Foundation for the National Institutes of Health
Mar 3, 2022 · Dr. Julie Gerberding, Merck’s chief patient officer and executive vice president, population health and sustainability, will be retiring in May, the Kenilworth-based pharmaceutical company announced Wednesday.
